Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scalp nerve block with bupivacaine ± liposomal bupivacaine in supratentorial tumor resection
ChiCTR2400082017Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Start
- Mar 2024
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of bupivacaine and liposomal bupivacaine in brain neoplasm (3 arms), sponsored by Second Affiliated Hospital of Guangzhou Medical University. Primary endpoints: Heart rate, Mean arterial pressure and 2 more. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
bupivacaineliposomal bupivacaine
03
Conditions
brain neoplasm
Beyond the preview
Go deeper on ChiCTR2400082017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082017.